| HOME >> BIOLOGY >> TECHNOLOGY |
Approvals II-30
Approvals pending II-30
Related Clinical Trials II-30
Sunitinib (Sutent(R) - Pfizer) II-30
Approvals II-30
Related Clinical Trials II-31
Sorafenib (Nexavar(TM) - Bayer / Onyx)II-31
Approvals II-31
Related Clinical Trials II-31
Dasatinib (SPRYCEL(R) - Bristol-Myers Squibb) II-32
Approvals II-32
Gefitinib (Iressa(R) - AstraZeneca) II-32
Iressa(R): A Controversial Anti-Cancer Drug II-32
Approvals II-33
Approvals Pending II-33
Related Clinical Trials II-33
Key Ongoing Clinical Trials on Iressa II-33
Lapatinib (Tyverb(R) / Tykerb(R) - Glaxo SmithKline) II-33
Approvals II-34
Related Clinical Trials II-34
Temsirolimus (TORISEL(TM) - Wyeth) II-34
Approvals II-34
Rapamycin (Rapamune(R) - Wyeth) II-34
Approvals II-34
Nilotinib (Tasigna(R) - Novartis) II-34
Approvals II-35
Approvals Pending II-35
Related Clinical Trials II-35
Everolimus (Afinitor(R) - Novartis) II-35
Approvals II-35
Approvals Pending II-35
Related Clinical Trials II-35
Small Molecule Kinase Inhibitor Drugs In Pipeline II-36
Pazopanib (Glaxo SmithKline) II-36
Approvals Pending II-36
Related Clinical Trials II-36
Vandetanib (Zactima(R) - AstraZeneca) II-36
Related Clinical Trials II-36
Cediranib (Recentin(TM) - AstraZeneca) II-37
Related Clinical Trials II-37
Ridaforolimus (Merck/ ARIAD) II-37
Related Clinical trials II-37
Bosutinib (Wyeth) II-38
Related Clinical Trials II-38
Alvocidib (Sanofi-Aventis) II-38
Related Clinical Trials II-38
Motesanib (Amgen/ Takeda) II-38
Related Clinical Trials II-38
CP-690550 (Pfizer) II-39
Related Clinical Trials I
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |